Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a phone app ease the journey through Weight-Loss surgery?

NCT ID NCT06061406

Symptom relief Sponsor: Wuerzburg University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 26, 2026 · Last updated Aug 27, 2026 · Updated 1 time

Summary

This trial tests whether a smartphone app can help people with obesity take a more active role in their care around bariatric (weight-loss) surgery. The app helps users track diet and exercise, report problems, and organize medical documents, with a nurse available to connect them to their care team if needed. About 100 adults—some preparing for surgery, some who had surgery at least two years ago, and some managing obesity without surgery—will use the app for a year. The study focuses on how satisfied people are with the app and how often they use it, rather than on weight loss itself.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A smartphone app called Smartvisit, adapted for obesity patients, to track diet, exercise, and symptoms, and to manage medical documents.
What this could lead to
If successful, this app could become a standard tool to help people with obesity manage their care before and after bariatric surgery, reducing the burden on clinics and improving patient outcomes.
What could go wrong
This is a small pilot study focused on satisfaction and usage, not on weight loss or health outcomes. The app may not be widely adopted or may not improve long-term care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

100 people

The number who actually took part.

Started

May 2021

Finished

Jun 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

General inclusion criteria: * Smartphone available (iOS or Android with sufficient version of the operating system). * Age \>/= 18 years * Sufficient language skills to answer the questionnaires Additional group specific inclusion criteria: Group 1 (bariatric-metabolic surgery): • Bariatric-metabolic surgery (sleeve gastrectomy, Roux-Y gastric bypass, omega-loop bypass) at least 24 months ago. Group 2 (multimodal treatment): • Participation in a full or partial (if primary indication) multimodal approach. Group 3 (conservative therapy): * BMI 28-34.9 kg/m2 * No planned bariatric-metabolic surgery * Desire for conservative weight reduction Exclusion Criteria: • current pregnancy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bariatric surgery candidate are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease Empowerment Obesity obesity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bariatric surgery candidate Obesity

Contacts and locations

Locations

  • Ann-Cathrin D Koschker

    Würzburg, 97080, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.